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Abstract
Sixty-one residents of Kiev region (16 individuals with nodular goiter and 45 individuals without thyroid pathology - the
control group) were examined. When studying urinary iodine excretion, median urinary iodine concentration in the control
group was 65.0 µg/l, while in patients with nodular goiter, it was 72.15 µg/l indicating mild iodine deficiency. In patients with
nodular goiter, there were observed decreased serum levels of calcium - 74.17 mg/l (p<0.05), magnesium - 17.67 mg/l,
zinc - 0.73 mg/l (p<0.05) and selenium - 0.03 mg/l (p<0.05) as compared to those in the control group. The relative risk of
developing nodular goiter in decreased serum calcium concentration was 1.66 (95% confidence interval 1.07-2.09), (p<0.05);
in decreased serum concentration of both calcium and selenium, it was 2.30 (95% confidence interval 1.147-4.085), (p<0.05);
in low serum magnesium concentration, the relative risk was 2.6 (95% confidence interval 1.11-6.09) (p<0.05).
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Problem statement and analysis of the
recent research
Nodular goiter (NG) is considered a multifactorial disease [1,
2]. This disorder occurs due to complex interaction of exoge-
nous and numerous endogenous factors. In case of thyroid
disfunction caused by various factors (iodine deficiency, inad-
equate iodine metabolism, inherited defects, etc.) hypophysis
can stimulate the thyroid gland leading to increased thyroid
stimulating hormone (TSH) production which results in the
formation of proliferative and hyperplastic nodules [3].
A number of authors believe that autocrine growth factors
such as insulin-like growth factor, epidermal growth factor, fi-
broblast growth factor play a significant role in the stimulation
of thyrocyte proliferation. These biological components are
physiological modulators of both thyrocyte proliferation and
apoptosis [4, 5]. According to its mechanism of action, iodine
bounds to tyrosyl residues of thyroglobulin (Tg), as well as
to lipids forming iodinated lactones and aldehydes. The latter
are considered as physiological inhibitors of autocrine growth
factors and their decreased concentration in thyroid glands
results in thyrocyte growth stimulation.
ND occurs not only due to iodine deficiency; other trace
element deficiency is associated with its development as well.
Trace elements (iron (I), calcium (Ca), selenium (Se), etc.)
deficiency increases the risk of ND development [6-9]. Se
and zinc (Zn) are proven to play a significant role in iodine
metabolism and their inadequate intake has a negative impact
on the thyroid gland. The effect of copper (Cu), manganese
and bromine on goiter pathogenesis is still studying [10, 11].
We have earlier reported the presence of iodine deficiency
almost throughout the whole territory of Ukraine and a con-
stant lack of iodine in the diet of people living in northern
regions of Ukraine [12-15]. We consider that the correla-
tion between the imbalance of macro- and trace elements in
humans and NG prevalence play a significant role in ND oc-
currence, whereas their mechanisms of action are remaining
unclear.
The objective of the research was to determine the features
of macro- and microelement provision of the population of
Kyiv region and their role in the ND development.
1. Materials and methods
The study included 61 adult volunteers at the age of 29-46
years residing in Kyiv region. All the participants were di-
vided into two groups: the control group comprised 45 (21
males and 24 females) volunteers at the age of (39.48±0.66)
years; the study group included 16 (10 females and 6 males)
volunteers with ND at the age of (39.0±1.26) years.
Urinary iodine concentrations (UIC) were measured using
the Sandell-Kolthoff reaction method modified by Dunn et al.
[16]. The results of the study were interpreted according to the
WHO recommendations [17]. The study of UIC undergoes
constant external quality control in the Center for Disease
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Control and Prevention (Atlanta, USA).
Thyroid ultrasound measurements were performed using
ultrasonographic scanner Terason 2000 with linear sensor and
a frequency of 10 MHz. The thyroid size was determined
according to the recommendations of Brunn J et al. [18]. ND
was defined when thyroid volume exceeded 15 cm3 for males
and 13 cm3 for females [19].
Serum macro- and microelements concentrations were
studied using inductively coupled plasma-atomic emission
spectroscopy (ICP-AES) according to the standard procedure
in the laboratory of analytical chemistry and toxicological
compound monitoring of Institute of Occupational Health of
the NAMS of Ukraine. The ICP-AES system consisted of
spectrophotometer Optima 2100 DV (Perkin Elmer, USA).
Blood samples of subjects were preliminary subjected to mi-
crowave treatment. The upper and lower limits of element
concentration in the blood samples were within the following
ranges: 17-28 mg/l for magnesium (Mg), 90-112 mg/l for Ca,
0.6-1.2 mg/l for Zn, 0.6-1.68 mg/l for I, 0.7-1.55 mg/l for Cu
and 0.046- 0.14 mg/l for Se [20].
Thyroid function was examined by the level of TST, free
thyroxine (FT4), Tg. The levels of total FT4 and TSH were
measured by radioimmunoassay analysis using reagent pack
(Amersham, UK). To study the levels of antibodies to Tg and
thyroxine peroxidase in the serum, an enzyme immunoassay
method was used using standard kits (Medizin, Germany).
Statistical processing of data was carried out in accordance
with the requirements of evidence-based medicine and bio-
statistics, applying the approaches of modern non-infectious
epidemiology [21, 22]. During the statistical analysis, the
software package SPSS 11.0 and MedStat were used. [23].
2. Results and discussion
When studying urinary iodine excretion, median UIC in the
control group was 65.0 [40.75-109.45] µg/l; in patients with
nodular goiter, it indicated mild iodine deficiency as well
(Table 1). In the control group, 28.8 % of individuals had
normal median urinary iodine levels (>100 µg/l), while 6.7 %
of volunteers had severe iodine deficiency (<20 µg/l). Among
patients with NG, 31.2 % individuals had normal median
urinary iodine levels (>100 µg/l), and 6.2 % of volunteers
had severe iodine deficiency (<20 µg/l).
Tg value is considered a criterion of more stable iodine de-
ficiency. In the control group, Tg level (9.3 [5.2-18.55] µg/l)
was similar to that in the study group, i.e., there was observed
no significant difference between both groups. TSH level
greater than 4 mIU/l was observed in 6.3% of participants in
the study group and 2.2% of participants in the control group.
Ultrasound examination revealed that the median of thyroid
volume was 10.75 [9.08-12.625] cm3, whereas in the control
group, this parameter was 11.05 cm3 [9.6-12.85]. The activa-
tion of immune processes in the thyroid gland was observed in
people with NG. Elevated level of thyroid peroxidase antibody
(TPOAb) titers of (24.4 [17.75-29.9] IU/ml) was observed in
the study group (p<0.05 as compared to the control group).
The experimental data of macro- and microelement dis-
tribution in the blood serum were summarized and analyzed.
Abnormal distribution of the sample results was detected;
therefore, the values of the median and quartile intervals of
the series are given.
In the control group, the median serum Ca level was 90.13
[72.34-103.94] mg/l, whereas in the study group, it was lower
(74.17 [52.36-88.91] mg/l, p<0.05, according to the Mann-
Whitney U-test) (Fig. 1).
In the control group, the median serum Mg level was
found to be 21.65 [19.41-26.67] mg/l and in the study group,
it was 17.66 [14.73-22.72] mg/l (p<0.05, according to the
Mann-Whitney U-test).
In the control group, the median serum Zn level was 0.88
[0.77-1.15] mg/l being higher the median serum Zn level in
the study group - 0.72 [0.51-0.84] mg/l (p<0.05, according to
the Mann-Whitney U-test).
In the control group, the median serum Fe level was 0.84
[0.67-1.12] mg/l. Fe level less than 0.6 mg/l was observed in
22.5 % of the participants, while in 2.5 % of individuals, the
level of Fe exceeded normal values. In the study group, the
median serum Fe level was 0.96 mg/l [0.47-1.41]. In 31.25%
of cases, Fe levels were less than optimal iron levels.
In the control group, the median serum Cu level was 0.91
[0.81-1.26] mg/l. In the study group, it was 0.92 [0.79-1.08]
mg/l. Cu deficiency was detected in 12.5 % patients with NG.
In the control group, the median serum Se level was 0.039
[0.03-0.11] mg/l. Se deficiency was detected in 67.5% of
volunteers. In the study group, serum Se level was 0.029
[0.024-0.047] mg/l (p<0.05, according to the Mann-Whitney
U-test) which being significantly lower than that in the control
group (Fig. 1).
The correlation between different element concentration in
the control group and the study group was investigated (Table
2). In the study, a significant (p<0.05) correlation between
Ca and Mg content was found (correlation coefficient (r) was
0.526). In the control group, a significant (p<0.01) correlation
was found between Ca and Cu content (r = 0.429).
In the control group, Fe level correlated with TPOAb level,
r = 0.332 (p<0.05). In the study group, there was correlation (r
= 0.511, p<0.05) between Fe level and thyroid gland volume,
Cu level and Tg concentration (r = 0.595, p<0.05), Mg level
and Tg level (r = 0.599, p<0.05).
The relative risk (RR) of NG development was estimated
in accordance with essential element level in the blood serum
on the basis χ2 for a 4-fold conjunction table with Fisher’s
correction.
In case of low Mg level, RR = 2.6 (95% CI 1.11-6.09),
(p<0.05), whereas in low serum Ca content, RR = 1.66 (95 %
CI 1.07-2.09). In simultaneous Ca and Se deficiency, RR =
2.30 (95 % CI 1.147-4.085), (p<0.05).
3. Conclusions
1. Mild iodine deficiency was observed in volunteers of
both the control group (72.1 µg/l) and the study group
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Table 1. Median UIC and thyroid status studied volunteers residing in Kyiv region
Parameters Control group Study groupMedian [Q1 – Q3] Median [Q1 – Q3]
(n) 45 16
UIC, µg/l 65.0 [40.75-109.45] 72.15 [47.45-111.45]
Tg, µg/l 9.3 [5.2-18.55] 8.65 [4.45-15.875]
Thyroid volume, cm3 11.05 [9.6-12.85] 10.75 [9.08-12.625]
TSH, mIU/l 1.2 [0.8-1.95] 1.7 [1.0-2.1]
FT4, pmol/l 16.3 [12.8-19.8] 14.95 [13.4-16.5]
TPOAb, IU/ml 19 [5.0-26.55] 24.4 [17.75-29.9]*
TgAbs, IU/ml 18 [7.0-23.5] 13.25 [8.425-24.55]
Notes:
Q1 – Q3 – 1-3 quartiles;
* p<0.05 as compared to the control group according to the Mann-Whitney U-test.
Figure 1. Analysis of serum macro- and trace element concentration in individuals with NG and the control group.
Note:
* p<0.05 – as compared to the control group.
Table 2. Correlation between macro- and microelements and thyroid status parameters in both groups
Correlation links between parameters Control group (n=45) Study group (n=16)rspearman p rspearman p
Ca/Mg 0.286 0.063 0.526 0.036
Ca/Cu 0.429 0.004 0.107 0.692
Fe/ TPOAb 0.332 0.03 -0.192 0.477
Fe/ Thyroid volume -0.005 0.947 0.511 0.043
Mg/TgAbs -0.034 0.827 0.599 0.014
Cu/Tg -0.041 0.794 0.595 0.015
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(65.0 µg/l) residing in Kyiv region.
2. Volunteers of the study group were found to have lower
serum Ca and Mg levels as compared to the control
group.
3. Patients with NG had lower serum Se concentration as
compared to the control group.
4. Patients with NG had lower serum Zn concentration as
compared to the control group.
5. There was a significant correlation between Ca and Mg
concentration in patients with NG.
6. In case of low Mg level, RR = 2.6 (95% CI 1.11-6.09),
(p<0.05), whereas in low serum Ca content, RR = 1.66
(95 % CI 1.07-2.09). In simultaneous Ca and Se defi-
ciency, RR = 2.30 (95 % CI 1.147-4.085), (p<0.05).
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